Goldman Sachs’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
Goldman Sachs's FLGT Position: Q3 2026 in Review
Goldman Sachs increased its Fulgent Genetics (FLGT) stake by 12% in Q3 2026, buying an estimated $735K and bringing the position to 344,541 shares worth $7.59M. The position accounts for ﹤0.01% of the portfolio, ranked #3500.
Goldman Sachs first reported a position in FLGT in Q3 2016 and has held it in 28 quarters since. The position peaked at $9.16M in Q4 2025. 142 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.
- Goldman Sachs held 344,541 shares of Fulgent Genetics worth $7.59M as of Q3 2026.
- Goldman Sachs bought 36,601 Fulgent Genetics shares in Q3 2026, an estimated $735K.
- Fulgent Genetics made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #3500 holding.
- Goldman Sachs first reported a position in Fulgent Genetics in Q3 2016 and has held it in 28 quarters since.
- Goldman Sachs's Fulgent Genetics position peaked at $9.16M in Q4 2025.
- 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.
Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.